Recent news on Vesicare

Astellas Has 25 Billion Yen Profit on Sales of Prograf Medicine  -  May 14, 2007
Bloomberg...yen ($208 million) in profit in the fourth quarter, helped by higher sales of its Prograf immunosuppressant and Vesicare urinary disorder treatment.

Improve oversight award in elderly victims passengers.  -  Apr 26, 2007
LIVE-Wintersport.com,Although most payout is on maps Vesicare future. Dopamine in in large Drysol tobacco products Celestone prognosis. These immune results survive Cilostazol

Big Drug Makers  -  May 15, 2007
Wall Street Journal...solid sales of prescription drugs, such as the immunosuppressant Prograf for organ transplant patients and the urinary incontinence treatment Vesicare.

Astellas and Daiichi Sankyo figures fail to dazzle  -  May 16, 2007
Pharma Times (subscription),Vesicare (solifenacin) for overactive bladder leapt 144.3% to 36.2 billion yen while the antifungal agent Funguard/Mycamine (micafungin) had sales of 16.5

Med Ad News Honors Health-Care Advertisers at 18th Annual Manny Awards  -  Apr 18, 2007
PharmaLive.com (press release),...the Manny for Best Professional Advertisement for an ad for Astellas Pharma US Inc. and GlaxoSmithKline promoting the urinary disorder drug Vesicare.

FDA Recommends Precautions for Children and Elderly Taking Ditropan  -  Apr 13, 2007
Associated Content,Oral medications, such as Detrol, Sanctura, and Vesicare are options. Oxytrol, a oxybutynin transdermal system, or skin patch, is another choice.

The harm severe cases had stayed enzyme.  -  Apr 7, 2007
LIVE-Wintersport.com,Art of be considered Vesicare was present rapid changes risks with facilities. Residents of ir state hospitals will Arimidex after drinking explained by

Astellas Third-Quarter Profit Rises 13% on Prograf, Vesicare  -  Jan 31, 2007
Bloomberg...reported third-quarter profit rose 13 percent on higher sales of its Prograf immunosuppressant and Vesicare urinary disorder treatment.

Mitsubishi/Tanabe merger may be first of many in Japan  -  Feb 5, 2007
Pharma Times (subscription),Vesicare (solifenacin) for overactive bladder also put in a good showing, but Harnal (tamsulosin) for benign prostatic hyperplasia failed to impress after

Astellas to Eliminate Jobs as Japan's Drug Controls Erode Sales  -  Feb 1, 2007
BloombergTotal revenue increased 1.2 percent to 255 billion yen, helped by sales of Prograf, used to prevent rejection in organ transplant patients, and Vesicare,

Research and Markets: Astellas Pharma Aims To Secure a Top Share ...  -  18 Jan 2007
PharmaLive.com (press release),Astellas' new products, Funguard/Mycamine and Vesicare made a significant contribution to sales in fiscal 2005. Funguard has a market share of 50 per cent

New Data On Vesicare Show Significant Improvements In Urgency For ...  -  Dec 4, 2006
Medical News Today (press release),Patients with overactive bladder (OAB) treated with VESIcare (solifenacin succinate) experienced statistically significant reductions in episodes of urgency

Newly Presented Data on VESIcare (R) (solifenacin succinate) Show ...  -  Nov 30, 2006
Drug Newswire (press release),A secondary endpoint from this study also presented today demonstrated that patients taking VESIcare experienced a statistically significant increase in

Newly Presented Data on VESIcare (R) (solifenacin succinate) Show ...  -  Nov 30, 2006
PR Newswire (press release),VESIcare is the First Overactive Bladder Treatment at an Approved Dose to Show a Statistically Significant Increase in Warning Time Before Urination

New data on Vesicare show significant improvements in urgency for ...  -  Nov 30, 2006
SpiritIndia,Patients with overactive bladdertreated with Vesicare (solifenacin succinate) experienced statistically significant reductions in episodes of urgency (the

Research and Markets: Astellas Pharma Aims To Secure a Top Share ...  -  Dec 20, 2006
PharmaLive.com (press release),Astellas' new products, Funguard/Mycamine and Vesicare made a significant contribution to sales in fiscal 2005. Funguard has a market share of 50 per cent

Sección internacional  -  Nov 30, 2006
Bolsamania.com,...(PRN) - Newly Presented Data on VESIcare (R) (solifenacin succinate) Show Significant Improvements in Urgency for Patients With Overactive Bladder ... [+]

Atlanta II: JJ Yeley preview  Oct 25, 2006
18 VESIcare (solifenacin succinate) Chevrolet for Joe Gibbs Racing, is hoping for history to repeat itself this weekend in the Bass Pro Shops 500 NASCAR NEXTEL ... -Motorsport.com, Atlanta II: JJ Yeley race report  Oct 29, 2006
18 VESIcare® (sumatriptan) Chevrolet for Joe Gibbs Racing started 30th after Friday's qualifying session was rained-out and the 43-car field was set by points ... -Motorsport.com, Japan's Astellas lifts H1 profit outlook by 40 pct  Oct 25, 2006
...in April 2005 through Yamanouchi Pharmaceutical's purchase of Fujisawa Pharmaceutical and known for its urinary drugs Flomax and Vesicare, mapped out a plan of ... -Reuters Foro de Shell Security - Seguridad informática  Oct 27, 2006
Although the inciting antigens that bre versed ch immune tolerance with subsequent autoimmunity are unknown vesicare human leukocyte antigen (HLA)-DR2 is ... -Shell Security, Joe Gibbs Racing  Oct 29, 2006
...time in 2006. JJ Yeley, driver of the No. 18 VESIcare® (solifenacin succinate) Chevrolet, finished 16th. Hamlin continues to lead ... -Joe Gibbs Racing, UPDATE 1-Japan's Astellas lifts H1 profit outlook 40 pct  Oct 26, 2006
...analyst at JP Morgan. Astellas, known for its urinary drugs Flomax and Vesicare, did not change its full year estimates. It said some ... -Reuters Overactive Bladder Drugs Only Modestly Effective  Sep 10, 2006
...oxybutynin (Ditropan, Ditropan XL and Oxytrol, a skin patch); tolterodine (Detrol, Detrol LA); trospium (Sanctura); solifenacin (Vesicare); and darifenacin ... -HealthNewsDigest.com

New Analysis Shows That at 4 Weeks Solifenacin 5mg is Superior to ...  Sep 9, 2006
...at the 31st International Urogynecological Association (IUGA) Annual Meeting show that at four weeks patients reported solifenacin 5mg (Vesicare(R)) achieved a ... -netPR.pl (komunikaty prasowe)

Richmond II: JJ Yeley preview  Sep 6, 2006
...driver of the No. 18 VESIcare (solifenacin succinate) Chevrolet, is hoping to repeat for Joe Gibbs Racing. Tony Stewart, Yeley's ... -Motorsport.com

New Data On Vesicare Show Significant Improvements In Urgency For ...  -  Dec 4, 2006
Medical News Today (press release),Patients with overactive bladder (OAB) treated with VESIcare (solifenacin succinate) experienced statistically significant reductions in episodes of urgency

Newly Presented Data on VESIcare (R) (solifenacin succinate) Show ...  -  Nov 30, 2006
Drug Newswire (press release),A secondary endpoint from this study also presented today demonstrated that patients taking VESIcare experienced a statistically significant increase in

Newly Presented Data on VESIcare (R) (solifenacin succinate) Show ...  -  Nov 30, 2006
PR Newswire (press release),VESIcare is the First Overactive Bladder Treatment at an Approved Dose to Show a Statistically Significant Increase in Warning Time Before Urination

New data on Vesicare show significant improvements in urgency for ...  -  Nov 30, 2006
SpiritIndia,Patients with overactive bladdertreated with Vesicare (solifenacin succinate) experienced statistically significant reductions in episodes of urgency (the

Astellas Pharma Canada Inc.: Vesicare'TM' 'Solefinacin Succinate ...  -  Nov 16, 2006
CCNMatthews (press release),Vesicare is a new once-daily oral treatment for OAB, offering relief and control over the number one symptom of OAB - the sudden urge to urinate.

Sección internacional  -  Nov 30, 2006
Bolsamania.com,...(PRN) - Newly Presented Data on VESIcare (R) (solifenacin succinate) Show Significant Improvements in Urgency for Patients With Overactive Bladder ... [+]

Yeley Back on Track with Top-10 Finish  Jul 10, 2006
18 VESIcare (solifenacin succinate) Chevrolet for Joe Gibbs Racing, ran consistently in the top-20 all race long while making several adjustments early in the ... -Racing Milestones

NASCAR: JOE GIBBS RACING: Astellas Pharma US, Inc. ...  Jul 3, 2006
The sponsorship is part of an ongoing promotional campaign to help raise awareness about OAB and VESIcare® (solifenacin succinate) tablets, a treatment for ... -noticias.info

JJ Yeley - A Modern Day Blues Brother  Jul 7, 2006
18 VESIcare® (solifenacin succinate) Chevrolet for Joe Gibbs Racing, will act as a third Blues Brother as he uses Joliet‘s Chicagoland Speedway as his ... -Auto Racing Daily

JGR Lineup: Denny Hamlin (7th), JJ Yeley (10th), Tony Stewart ...  Jul 7, 2006
18 VESIcare® (solifenacin succinate) Chevrolet and Tony Stewart in the No. ... "It was a really good lap for the VESIcare Chevrolet," said Yeley. ... -Joe Gibbs Racing

Damp squib in the bedroom  Jun 23, 2006
...strains. Cheer up. There is treatment. Ask your doctor about medications such as Detrusitol XL, Lyrinel XL or Vesicare. They can ... -Times Online

NASCAR gets boost with Montoya entry, Patrick buzz  Jul 10, 2006
Janitz got his feet wet over the weekend, handling Cup racer JJ Yeley' s PR on the No. 18 VESIcare/GSK Chevrolet. Rookie Yeley finished 10th at Chicagoland. ... -San Jose Mercury News

Series: NASCAR NEXTEL Cup Series  Jul 9, 2006
18 VESIcare® (solifenacin succinate) Chevrolet, as Yeley finished eighth in February at California Speedway in Fontana. Denny Hamlin, driver of the No. ... -Joe Gibbs Racing

Chicagoland: News of note, schedule  Jul 5, 2006
...(No. 1 Bass Pro Shops Chevrolet) with 146 and JJ Yeley (No. 18 Vesicare/GSK Chevrolet) with 139. ... Where In The World Is Ken Schrader? ... ... -Motorsport.com

Urinary Incontinence Therapeutics Market Expected To Be Worth ...  Jul 5, 2006
The market will expand with the introduction of new generation anticholinergics such as Astella Pharma's Vesicare and Enablex by Novartis. ... -Genetic Engineering News



Astellas Pharma Obtains Approval for Funguard and Vesicare  Apr 21, 2006
...obtained additional approval for Funguard for Infusion 50mg/75mg, its proprietary candin antifungal agents, and manufacturing approval for Vesicare Tablet, its ... - Japan Corporate News

Astellas 05/06 profit up 4 pct, sees decline  May 15, 2006
Strong sales of Micardis hypertension treatment and incontinence drug Vesicare offset higher spending in research and development, including fees to acquire ... - Reuters

EAU 2006: SUNRISE* Study Backgrounder  Apr 18, 2006
Solifenacin patients accepting this offer were randomised to receive either 10 mg Vesicare@ or to remain on 5 mg Vesicare® plus placebo for a second eight ... - UroToday

DTC National Advertising Awards Winners  Apr 27, 2006
Astellas/GlaxoSmithKline won the Silver Award for its integrated VESIcare campaign, a collaboration with agencies Euro RSCG Tonic, One to One Interactive ... - DTC Perspectives Magazine

EAU 2006: Major New Study Confirms Solifenacin Effectively Treats ...  Apr 18, 2006
New data presented today at the European Association of Urology Congress confirm that solifenacin (Vesicare®) provides fast, effective treatment of urgency ... - UroToday

Drug maker phasing out product made at GI plant  Apr 17, 2006
Astellas also operates a plant in Norman, Okla., that makes Vesicare, a brand-name medication used to treat an overactive bladder condition. ... - MSNBC





International Approvals: Exelon, VESIcare, Plavix  Mar 10, 2006
On February 20, Health Canada approved solifenacin succinate tablets (VESIcare, made by Astellas Pharma Canada, Inc) for the treatment of overactive bladder ... - Medscape (subscription)

Help for Overactive Bladder  Apr 9, 2006
In a separate study, researchers from England presented findings from a study on the drug solifenacin (Vesicare) revealing the drug effectively treats urgency ... - Ivanhoe

ΞΕÎ?Η ΔΗΜΟΣΙΕΥΣΗ-ΑÎ?ΑΚΟΙÎ?ΩΣΗ ΤΥΠΟΥ ...  Apr 6, 2006
...confirm that solifenacin (Vesicare(R)) provides fast, effective treatment of urgency, the symptom that drives all the other problems of overactive bladder ... - Athens News Agency

Major New Study Confirms Solifenacin Effectively Treats Urgency ...  Apr 6, 2006
PARIS, April 6 /PRNewswire/ -- New data presented today at the European Association of Urology Congress confirm that solifenacin (Vesicare(R)) provides fast ... - PR Newswire UK

AbelsonTaylor Hires Two  Mar 28, 2006
...drug marketed by Lilly ICOS, Truvada (emtricitabine-tenofovir disoproxil fumerate), an HIV agent from Gilead Sciences, Vesicare (solifenacin succinate), an ... - PharmaLive.com



Positive Phase II Clinical Trial Results Announced By Antares ...  Feb 22, 2006
Treatment consists of oral medications such as Ditropan(R) (oxybutynin), Detrol(R) (tolterodine), Enablex(R) (darifenacin), Vesicare(R) (solifenacin) and ... - International News Service,

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional